Navigation Links
New drug dramatically improves survival in Hodgkin lymphoma patients
Date:6/27/2012

MAYWOOD, Il. -- A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of options.

Loyola University Medical Center oncologist Scott E. Smith, MD, PhD presented survival data for the drug, brentuximab vedotin (Adcetris), at the 17th Congress of the European Hematology Association. Smith is director of Loyola's Hematological Malignancies Research Program.

The multi-center study included 102 Hodgkin lymphoma patients who had relapsed after stem cell transplants. Tumors disappeared in 32 percent of patients and shrank by at least half in 40 percent of patients. An additional 21 percent of patients experienced some tumor shrinkage. Only 6 percent of patients had no response to the drug.

Sixty five percent of patients were alive at 24 months, and in 25 percent of patients, the cancer had not progressed at all.

These are "encouraging results in patients with historically poor prognosis," researchers said.

Loyola patient Michelle Salerno had failed two stem cell transplants -- one using her own cells and one using cells donated by her brother -- and multiple rounds of chemotherapy before going on brentuximab vedotin. After three or four infusions, she stopped suffering chills, sweats, high fevers and itchy pain from head to toe. And she experienced almost none of the side effects common to chemotherapy.

"I kept my hair, and never felt like vomiting," she said. "You get the drug, you go home, you feel good."

The standard regimen is a 30-minute infusion every three weeks. A patient typically receives 16 doses over 48 weeks.

Loyola has administered about 500 doses to 60 patients. "A lot of our patients are doing great on this regimen," Smith said.

Hodgkin lymphoma is a cancer of the immune system. Most patients can be cured with chemotherapy or radiation, especially when the disease is diagnosed
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Lung nodule matching software dramatically increases radiologists efficiency
2. US Drug Watchdog Dramatically Increases Their Efforts To Get All Recalled DePuy ASR Hip Implant Recipients Identified To The Best Possible Attorneys Before Time Runs Out
3. Automated breast ultrasound dramatically reduces physician interpretation time
4. Saliva test could dramatically increase detection of oral cancer
5. Invasive heart test being dramatically overused, Stanford study shows
6. Experimental drug improves muscle strength among male cancer patients
7. New delivery method improves efficacy of 2 common Parkinsons disease medications
8. Sleep improves functioning in Parkinsons patients, but reasons remain elusive
9. PAP therapy improves depressive symptoms in all patients with sleep apnea
10. STeleR study: Telerehab improves functioning after stroke
11. Tiny implanted coil improves lung function in patients with severe emphysema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Hong Kong (PRWEB) , ... July 07, 2015 , ... At the end of June ... first steps to ‘go green’ . This initiative, spearheaded by the Renewals Manager, Danielle Cotton, ... Hong Kong office. , On this initiative Cotton explained, “We send anything between 300 ...
(Date:7/7/2015)... Michigan (PRWEB) , ... July 07, 2015 , ... On ... fundraising golf outing at the Manistee Golf and Country Club. Best Drug Rehabilitation staff ... to a good cause, helping underprivileged children. Kiwanis International, the parent of the Manistee ...
(Date:7/7/2015)... ... 07, 2015 , ... With a new community program in the San Antonio, ... announced a new charity campaign to raise funds in support of programs for veterans. ... was created especially to care for the special needs of our soldiers. Clear ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... Purdy as the company’s new Chief Financial Officer, effective July 6th, 2015. Ellen ... in companies ranging from a multi-billion dollar, global chemical company to early and ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... law announce the launch of their new website, the Invokana Ketoacidosis Lawsuit ... FDA warning*, and serves as a resource for persons wishing to learn more ...
Breaking Medicine News(10 mins):Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3Health News:Office Practicum Announces new CFO 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3
... 1 America,s Health Insurance Plans (AHIP) President and ... the announcement from the Centers for Medicare and Medicaid ... the country continue to have access to affordable, high-quality ... health plans offer innovative services and provide essential health ...
... American Association for Cancer Research will hold its first ... 2009, when it gathers for the Frontiers in Basic ... include presentations from past and future AACR Presidents as ... such as epigenetics, targeted small molecules, systems biology and ...
... Singapore and Washington DC (October 1, 2009) Self-monitoring of ... their behavior, adjust their medicine and understand their disease ... published by SAGE in The Diabetes Educator . ... both before and after specific events, to evaluate whether ...
... ... has been designated International LDN Awareness Week, to focus media attention on the successful use ... respond well to LDN, including Multiple Sclerosis, Crohn,s disease, Lupus and Fibromyalgia. Immune system dysfunction ... on Oct. 19th, 2009. , ...
... Cynthia Perkins, M.Ed., publishes new book, Get ... provide alcoholics with the little known facts they need ... The Truth About Alcoholism provides an invaluable review ... successful treatment! Despite past decades of unrelenting failure rates ...
... Scientists from the U.S. Department of Energy,s Lawrence ... uncovered the role played by the least-understood part of ... repair breaks in DNA strands, a process that helps ... the puzzle in place, scientists can better understand how ...
Cached Medicine News:Health News:AHIP Statement on Today's CMS Announcement 2Health News:AHIP Statement on Today's CMS Announcement 3Health News:International LDN Awareness Week, October 19 - 25th, 2009 2Health News:International LDN Awareness Week, October 19 - 25th, 2009 3Health News:International LDN Awareness Week, October 19 - 25th, 2009 4Health News:International LDN Awareness Week, October 19 - 25th, 2009 5Health News:New Book Provides Alcoholics with Hope for Stable, Long-Term, Craving-Free Sobriety 2Health News:Scientists decipher missing piece of first-responder DNA repair machine 2Health News:Scientists decipher missing piece of first-responder DNA repair machine 3
(Date:7/7/2015)... Ill. , July 7, 2015  Monopar Therapeutics ... oncology compounds, announced that its co-founder and CEO, ... British Council,s Education U.K. Alumni Entrepreneurial Award. The British ... China , India , and ... recognizes outstanding achievements made by entrepreneurs who have leveraged ...
(Date:7/7/2015)... SAN DIEGO , July 7, 2015 /PRNewswire/ ... pharmaceuticals, announced today initiation of enrollment and dosing ... clinical study of ABX-1431, a first-in-class, investigational endocannabinoid ... technology platform, which finds new small molecule drug ... of enzymes with important regulatory roles in human ...
(Date:7/7/2015)... NEW YORK , July 7, 2015  New ... treated with radiation therapy versus surgery for prostate ... University of Toronto presented their findings at the ... last month, which further suggest that prostate ... increased risk of requiring minimally invasive urologic procedures due ...
Breaking Medicine Technology:Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 2Abide Therapeutics Announces First Subject Dosed in First-in-Human Clinical Study of ABX-1431, an Investigational Endocannabinoid System Modulator 3New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 2New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 3New Study Shows Surgery Has Less Side Effects and Long-Term Issues Over Radiation for Treating Prostate Cancer 4
... /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... medical devices worldwide, today announced shareholder resolutions adopted at ... Kong on December 22, 2010. At the ... Ms. Joyce I-Yin Hsu and Mr. Wu Qiyao, each ...
... Inc. (Nasdaq: CEPH ) today announced that ... the U.S. Food and Drug Administration (FDA) for the ... [C-IV] for the treatment of patients with excessive sleepiness ...  In its letter to the company, the FDA reiterated ...
Cached Medicine Technology:Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 2Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 3
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
Medicine Products: